drugset / Trial / NCT00977028

Tumescent Lidocaine Maximum Safe mg/kg Dosage

NCT00977028

Phase 1/2 Unknown 14 enrolled Klein, Jeffrey A., M.D.
Non-randomizedSingle-groupOpen-labelTreatment

Summary

This pharmacokinetic clinical trial is a dose ranging study of lidocaine in tumescent local anesthesia. The goal is to understand the absorption pharmacokinetic of tumescent lidocaine and to determine an objective (statistical) estimate of the maximum safe mg/kg dosage of lidocaine in tumescent local anesthesia without liposuction.

Timeline

Start
2005-01
Primary completion
2011-07
Completion
2011-08

Drugs

EvaluationDrugModalityDoseRoute
Subject Epinephrine Other / unclassified Subcutaneous
Subject Lidocaine Other / unclassified 45 mg/kg Subcutaneous

Indications

No indication recorded.